Announcing the 2025 End AxD Grant Program Recipients

End AxD is proud to announce the recipients of the inaugural 2025 End AxD Grant Program. Following a review of 24 applications from around the world, the End AxD Scientific Advisory Committee has recommended five pioneering research projects for funding.

This year’s program represents an initial 2025 commitment of $263,419 with potential for year two investment of $266,928, pending mid-term progress reports.

End AxD’s investment strategy this year focuses not only on advancing the therapeutic pipeline but also on deepening our understanding of fundamental disease mechanisms and building high-value, long-term tools, such as specialized antibodies and protein ligands, that will empower the wider research community to accelerate discoveries that will lead to potential treatments.

You can read the full grant award announcement here.